CureVac Stock Pops Bullishly After Inking Deal With Bayer For Coronavirus Vaccine

Daily Updates

CureVac stock popped in bullish volume Thursday after the company inked a collaboration deal with Bayer (BAYRY) for its coronavirus vaccine.


Under terms of the agreement, Bayer will support further development, supply and key territory operations for CureVac‘s (CVAC) experimental coronavirus vaccine. Both companies are based in Germany.

“We are very happy to join forces with Bayer, whose expertise and infrastructure will help us make our vaccine candidate (called) CVnCoV even more rapidly available to as many people as possible,” CureVac Chief Executive Franz-Werner Haas said in a written statement.

In afternoon trading on the stock market today, CureVac stock jumped 18.7% near 103.10 in huge volume. Bayer stock edged 2.2% higher, near 16.20.

CureVac Stock Jumps Bullishly

CureVac is using a messenger RNA approach to its coronavirus vaccine. Similar to Pfizer‘s (PFE) vaccine with BioNTech (BNTX) and Moderna‘s (MRNA), these vaccines hijack the body’s process for protein creation.

CureVac will hold the marketing authorization for the coronavirus vaccine, while Bayer will support operations within the European Union and some additional markets. Bayer will have the option to become the marketing authorization holder in markets outside Europe.

The companies hope to supply hundreds of millions of doses around the world, pending approvals.

The news prodded CureVac stock to gap up. Shares broke out of a cup base with a buy point at 85.10 on Nov. 16. But on Dec. 31, CureVac stock fell as much as 9.2% below that entry. That triggered a sell rule when shares dive 7%-8% below a buy point.

CureVac stock started forming that cup base in August, a day after shares went public, according to

Follow Allison Gatlin on Twitter at @IBD_AGatlin.


Genetics Stocks Pop After Intellia Offers Update For Gene-Editing Drugs

Medical Stock Mashup: PerkinElmer, Oxford Unite In $591 Million Deal

Get Timely Buy & Sell Alerts With IBD Leaderboard

Learn How To Time The Market With IBD’s ETF Market Strategy

Looking For The Next Big Stock Market Winners? Start With These 3 Steps

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *